Literature DB >> 12384971

Ascertainment adjustment in complex diseases.

David V Glidden1, Kung-Yee Liang.   

Abstract

Genetic studies of complex diseases must confront two statistically difficult issues simultaneously. First, in many settings, to minimize the number of individuals to be genotyped, families enriched for disease must be oversampled. Also, statistical models in family studies should allow for residual association. This association will represent unmeasured genetic and environmental factors influencing disease risk. Dealing with these features simultaneously is both compelling and challenging. Burton et al. [2000] (Am. J. Hum. Gen. 69: 1505-14) recently discussed this issue and suggested that ascertainment corrections may lead to problematic parameter estimation. We revisit the issues and examples of Burton et al. [2000] (Am. J. Hum. Genet. 69: 1505-14) and present a more optimistic assessment. Estimation in this context is conceptually straightforward, but may be more problematic in practice. Specifically, we find that even slight misspecification of the random effects distribution in ascertainment-adjusted likelihood can yield severely biased parameter estimates. This result should make scientists wary when interpreting results from ascertainment-adjusted variance-component models. . Copyright 2002 Wiley-Liss, Inc.

Mesh:

Year:  2002        PMID: 12384971     DOI: 10.1002/gepi.10204

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  10 in total

1.  Ascertainment-adjusted maximum likelihood estimation for the additive genetic gamma frailty model.

Authors:  Wanlong Sun; Hongzhe Li
Journal:  Lifetime Data Anal       Date:  2004-09       Impact factor: 1.588

2.  Population-Calibrated Gene Characterization: Estimating Age at Onset Distributions Associated With Cancer Genes.

Authors:  Edwin S Iversen; Sining Chen
Journal:  J Am Stat Assoc       Date:  2005       Impact factor: 5.033

3.  A Variance-Component Framework for Pedigree Analysis of Continuous and Categorical Outcomes.

Authors:  Michael P Epstein; Jessica E Hunter; Emily G Allen; Stephanie L Sherman; Xihong Lin; Michael Boehnke
Journal:  Stat Biosci       Date:  2009-11

4.  Genomewide scan for real-word reading subphenotypes of dyslexia: novel chromosome 13 locus and genetic complexity.

Authors:  Robert P Igo; Nicola H Chapman; Virginia W Berninger; Mark Matsushita; Zoran Brkanac; Joseph H Rothstein; Ted Holzman; Kathleen Nielsen; Wendy H Raskind; Ellen M Wijsman
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2006-01-05       Impact factor: 3.568

5.  Outcome-dependent sampling from existing cohorts with longitudinal binary response data: study planning and analysis.

Authors:  Jonathan S Schildcrout; Patrick J Heagerty
Journal:  Biometrics       Date:  2011-04-02       Impact factor: 2.571

6.  Behavioral and Molecular Genetics of Reading-Related AM and FM Detection Thresholds.

Authors:  Matthew Bruni; Judy F Flax; Steven Buyske; Amber D Shindhelm; Caroline Witton; Linda M Brzustowicz; Christopher W Bartlett
Journal:  Behav Genet       Date:  2016-11-09       Impact factor: 2.805

7.  The effect of misspecification of random effects distributions in clustered data settings with outcome-dependent sampling.

Authors:  John M Neuhaus; Charles E McCulloch
Journal:  Can J Stat       Date:  2011-07-27       Impact factor: 0.875

8.  Outcome vector dependent sampling with longitudinal continuous response data: stratified sampling based on summary statistics.

Authors:  Jonathan S Schildcrout; Shawn P Garbett; Patrick J Heagerty
Journal:  Biometrics       Date:  2013-02-14       Impact factor: 2.571

9.  Fitting ACE structural equation models to case-control family data.

Authors:  K N Javaras; J I Hudson; N M Laird
Journal:  Genet Epidemiol       Date:  2010-04       Impact factor: 2.135

10.  Matched ascertainment of informative families for complex genetic modelling.

Authors:  Benjamin H Yip; Marie Reilly; Sven Cnattingius; Yudi Pawitan
Journal:  Behav Genet       Date:  2009-12-24       Impact factor: 2.805

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.